Ws Management Lllp Biomarin Pharmaceutical Inc Transaction History

Ws Management Lllp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$74.73 - $90.69 $108,582 - $131,772	-1,453 Reduced 4.48%	30,953 $2.34 Million
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $461,628 - $720,848	-5,803 Reduced 15.19%	32,406 $4 Million
Q1 2020 May 13, 2020	SELL	$71.37 - $96.85 $141,812 - $192,440	-1,987 Reduced 4.94%	38,209 $3.23 Million
Q3 2019 Nov 13, 2019	SELL	$67.4 - $85.11 $308,624 - $389,718	-4,579 Reduced 10.23%	40,196 $2.71 Million
Q2 2019 Aug 13, 2019	SELL	$80.35 - $93.9 $439,273 - $513,351	-5,467 Reduced 10.88%	44,775 $3.84 Million
Q1 2019 May 13, 2019	SELL	$84.2 - $98.62 $584,011 - $684,028	-6,936 Reduced 12.13%	50,242 $4.46 Million
Q4 2018 Feb 12, 2019	SELL	$80.14 - $106.07 $650,897 - $861,500	-8,122 Reduced 12.44%	57,178 $4.87 Million
Q2 2018 Aug 13, 2018	BUY	$76.01 - $99.03 $4.96 Million - $6.47 Million	65,300 New	65,300 $6.15 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Ws Management Lllp with notifications on news.